QXL-138AM is under clinical development by Nammi Therapeutics and currently in Phase I for Gastrointestinal Tract Cancer. According to GlobalData, Phase I drugs for Gastrointestinal Tract Cancer have ...

Nammi Therapeutics (Nammi) is a immuno-oncology company developing products for the treatment of cancer. The company product portfolio includes QLX138AM, SLNP-IC1 and NTI-121. Nammi’s lead product ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Aerosol droplets are unique microcompartments containing microscopic amounts of ...

Researchers at the University of Tsukuba have developed an innovative method for rapidly creating laser light sources in large quantities using an inkjet printer that ejects laser-emitting droplets.